COVID-19 Infection in Patients With Chronic Pulmonary Diseases.
试验速览
- 阶段
- 不适用
- 入组人数
- 100
- 主要终点
- Effect of COVID-19 on patients with chronic pulmonary diseases
研究概览
简要总结
This study aims to assess the clinical presentation, radiological patterns and outcome of COVID-19 infection in patients with chronic pulmonary disease.
Inter-relationship between the severity of COVID-19 infection and chronic pulmonary diseases.
详细描述
The COVID-19 pandemic has led to many difficulties with the diagnosis and routine management of chronic pulmonary diseases such as COPD, Bronchial asthma, ILD and Bronchiectasis as well as raising concerns about the management and outcomes for patients with these diseases who develop COVID-19.
Although there is conflicting evidence on whether patients with chronic respiratory diseases are more susceptible to COVID-19, these patients exhibit a more severe presentation and higher mortality compared with those without chronic respiratory diseases.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Cross Sectional
入排标准
- 年龄范围
- 16 Years 至 100 Years（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subjects with confirmed diagnosis of COVID-19 infection by:
- •RT-PCR And Chest Computed tomography and laboratoty investigations. Patients with chronic chest disease including (COPD, bronchial asthma, ILD, bronchiectasis).
排除标准
- •Those who are diagnosed with viral pneumonia caused by viruses other than COVID-
- •Those who are not confirmed to be COVID-19 with PCR or by radiological and laboratory investigations.
结局指标
主要结局
Effect of COVID-19 on patients with chronic pulmonary diseases
时间窗: 2 weeks after patient confirmation of infection by COVID-19
次要结局
未报告次要终点
研究者
Mostafa Mahmoud Elsayed
Principal Investigator
Sohag University